Cited by 96Diabetes Management and ResearchRace, Genetics, and SocietyDiabetes, Cardiovascular Risks, and Lipoproteins

Are there clinical implications of racial differences in HbA1c? A difference, to be a difference, must make a difference

Open access
Selvin, Elizabeth·2016·Diabetes Care

Abstract

Studies that have compared HbA1c levels by race have consistently demonstrated higher HbA1c levels in African Americans than in whites. These racial differences in HbA1c have not been explained by measured differences in glycemia, sociodemographic factors, clinical factors, access to care, or quality of care. Recently, a number of nonglycemic factors and several genetic polymorphisms that operate through nonglycemic mechanisms have been associated with HbA1c Their distributions across racial groups and their impact on hemoglobin glycation need to be systematically explored. Thus, on the basis of evidence for racial differences in HbA1c, current clinical guidelines from the American Diabetes Association state: "It is important to take…race/ethnicity…into consideration when using the A1C to diagnose diabetes." However, it is not clear from the guidelines how this recommendation might be actualized. So, the critical question is not whether racial differences in HbA1c exist between African Americans and whites; the important question is whether the observed differences in HbA1c level are clinically meaningful. Therefore, given the current controversy, we provide a Point-Counterpoint debate on this issue. In the preceding point narrative, Dr. Herman provides his argument that the failure to acknowledge that HbA1c might be a biased measure of average glycemia and an unwillingness to rigorously investigate this hypothesis will slow scientific progress and has the potential to do great harm. In the counterpoint narrative below, Dr. Selvin argues that there is no compelling evidence for racial differences in the validity of HbA1c as a measure of hyperglycemia and that race is a poor surrogate for differences in underlying causes of disease risk.-William T. CefaluEditor in Chief, Diabetes Care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc16-0042

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other studies have demonstrated higher A1C levels in African American participants than in White participants at a given mean glucose concentration.

    “Other studies have also demonstrated higher A1C levels in African American participants than in White participants at a given mean glucose concentration (15,16).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Selvin, E.
Affiliations
Johns Hopkins University (US)
Corresponding author
Selvin, Elizabeth
Venue
Diabetes Care
Published
2016-07-12
Volume
39
Issue
8
Pages
1462-1467
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2481518965
Cited by
96
References
73
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 10 · 2022: 9 · 2021: 19 · 2020: 13 · 2019: 12 · 2018: 10 · 2017: 7 · 2016: 4
FWCI
11.05
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (2R01DK089174, K24DK106414)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Race, Genetics, and Society
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
HbA1c, racial differences, African Americans, diabetes diagnosis, glycemic control, hemoglobin glycation, genetic polymorphism, clinical significance, American Diabetes Association guidelines
MeSH terms
Aged, Black or African American, Blood Glucose, Decision Making, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hyperglycemia, Cholesterol, HDL, Cholesterol, LDL, Middle Aged, Prognosis, Risk Factors, Socioeconomic Factors, Triglycerides, Reproducibility of Results, White People, Atherosclerosis, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review